Advent International, a privately owned firm headquartered in the US, was founded in 1984 and employs approximately 970 individuals. It operates as venture capital and private equity principals, investing in sectors including technology, media and telecoms, financial services, and healthcare.
Advent International announced on August 20 a majority investment in New Zealand Clinical Research Group (NZCR Group), a clinical-trials operator in New Zealand and Australia. Physician shareholders, management, and existing investor Waterman Capital will retain a significant minority stake, with the deal's close targeted for the fourth quarter, subject to regulatory approvals. Earlier, on August 18, PayPal reportedly resumed takeover discussions with a consortium including Advent International and Stripe, following a July proposal that valued PayPal at approximately $53 billion, or $60.50 per share. Also on August 18, IS Iris Lux Bidco S.à r.l., the company established by Advent International, FedEx, A&R Investments, and PPF Group for its offer for InPost, secured unconditional competition clearance from the European Commission, advancing the proposed €7.8 billion takeover.
Subscribe for full access to Advent International's products in full detail
Subscribe for full access to Advent International's revenue in full detail
Subscribe for full access to Advent International's products in full detail 
